Lundbeck
Murat Yildirim, MD, PhD, serves as a Senior Global Medical Advisor in the Medical Affairs, Medical Strategy and Communication Department of Psychiatry at Lundbeck since June 2010, focusing on aripiprazole formulations for schizophrenia and bipolar I disorder. Previous roles at Lundbeck include Global Medical Advisor and Principal Global Safety Physician, overseeing multiple psychiatric and neurological medications. Prior experience includes a Medical Manager position at Roche in oncology and post-doctoral research appointments at prestigious institutions such as Gülhane Military Medical Academy, Icahn School of Medicine at Mount Sinai, and Yale University School of Medicine. Education includes a PhD in Pharmacology and an MD in Medicine, both from Hacettepe University.
Lundbeck
42 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.